Great Point Partners LLC Axsome Therapeutics, Inc. Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $284,975 - $414,956	4,963 New	4,963 $395,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $4.99 Million - $9.88 Million	-100,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $4.11 Million - $10.1 Million	99,846 Added 39309.45%	100,100 $5.89 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $4,244 - $26,984	254 New	254 $26,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.